Published on Monday October 01, 2018

Smooth has started to work on the following projects:

  • Our company launches a phase II trial in AML for an international Sponsor.
  • Smooth prepares to launch a bioequivalence trial in arthritis for a global pharmaceutical company.
  • Our company is singing an agreement for a phase I clinical trial in stress disorder for a Russian company.

We reached important milestones in the following projects:

  • Smooth clinical team received an approval for conduct of a trial of an innovative orphan drug in ALD.
  • Our clinical team accomplished enrolment of patients in two phase III trials for a Russian and European Sponsors.

In the nearest future Smooth Corporate development team will attend:

  • Outsourcing in Clinical Trials, Mid-Atlantic, October 2-4, Silver Spring Maryland, USA.